C. Christiansen

发表

Unchanged parathyroid function following irradiation for malignancies of the head and neck

I. Holten, C. Christiansen, 1984, Cancer.

GWAS of bone size yields twelve loci that also affect height, BMD, osteoarthritis or fractures

A. Uitterlinden, J. V. van Meurs, E. Zeggini, 2019, Nature Communications.

Does carbamazepine cause disturbances in calcium metabolism in epileptic patients?

L. Nilas, C. Christiansen, L. Tjellesen, 1983, Acta neurologica Scandinavica.

Raloxifene reduces atherosclerosis: studies of optimized raloxifene doses in ovariectomized, cholesterol‐fed rabbits

C. Christiansen, J. Haarbo, R. Kauffman, 2000, Clinical endocrinology.

Hormone replacement therapy prevents coronary artery disease in ovariectomized cholesterol‐fed rabbits

B. Hansen, J. Haarbo, Claus Christiansen, 1991, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Treatment-Induced Cyclic Variations in Serum Lipids, Lipoproteins, and Apolipoproteins After 2 Years of Combined Hormone Replacement Therapy: Exaggerated Cyclic Variations in Smokers

J. Haarbo, C. Christiansen, 1992, Obstetrics and gynecology.

Effect of estrogen/gestagen and 24R,25‐dihydroxyvitamin D3 therapy on bone formation in postmenopausal women

B. Riis, K. Thomsen, C. Christiansen, 1986, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Skeletal osteoporosis

C. Christiansen, C. Christiansen, 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

PHOTON ABSORPTIOMETRY STUDIES IN OSTEOPOROSIS

C. Christiansen, 1985, Acta obstetricia et gynecologica Scandinavica. Supplement.

Cyproterone acetate, an alternative progestogen in postmenopausal hormone replacement therapy? Effects on serum lipids and lipoproteins

C. Christiansen, B. Riis, J. Jensen, 1987, British journal of obstetrics and gynaecology.

Influence of menopause on serum lipids and lipoproteins.

C. Christiansen, L. Nilas, J. Jensen, 1990, Maturitas.

Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause.

C. Christiansen, A. Gotfredsen, J. Haarbo, 1991, Metabolism: clinical and experimental.

Impact of soft tissue on in vivo accuracy of bone mineral measurements in the spine, hip, and forearm: A human cadaver study

C. Christiansen, C. Hassager, V. Skødt, 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Low bone mass and high bone turnover in male long distance runners.

C. Christiansen, M. Hetland, C Christiansen, 1993, The Journal of clinical endocrinology and metabolism.

Bone mass, bone structure and vertebral fractures in osteoporotic patients.

C. Christiansen, J. Pødenphant, B. Riis, 1987, Bone.

Iliac crest biopsy in longitudinal therapeutic trials of osteoporosis.

C. Christiansen, J. Pødenphant, B. Riis, 1988, Bone and mineral.

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women

Jacques P. Brown, A. Silman, S. Cummings, 2007, Osteoporosis International.

Incorporation and distribution of strontium in bone.

C. Christiansen, P. Delmas, S. Dahl, 2001, Bone.

C. Christiansen, L. Nilas, A. Gotfredsen, 1988, Bone and mineral.

Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis.

C. Christiansen, P. Delmas, R. Recker, 2004, Bone.

The effect on bone mass and bone markers of different doses of ibandronate — A new bisphosphonate for prevention and treatment of postmenopausal osteoporosis. A 1-year, randomized, double-blind, placebo-controlled dose-finding study

C. Christiansen, P. Ravn, B. Clemmesen, 2006, Osteoporosis International.

Ef ﬁ cacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial

T. Spector, H. Genant, N. Bellamy, 2015 .

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

C. Christiansen, P. Ross, C. Chilvers, 1998, The New England journal of medicine.

Dual energy X-ray absorptiometry of the spine--decubitus lateral versus anteroposterior projection in osteoporotic women: comparison to single energy X-ray absorptiometry of the forearm.

C. Christiansen, C. Hassager, L. Nilas, 1995, Bone.

Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women.

C. Christiansen, M. Christensen, I. Transbøl, 1982, The Journal of clinical endocrinology and metabolism.

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.

C. Christiansen, P. Delmas, B. Mitlak, 1997, The New England journal of medicine.

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture

Daniel L. Koller, D. Kiel, A. Uitterlinden, 2012, Nature Genetics.

Dual-energy x-ray absorptiometry: a precise method of measuring bone mineral density in the lumbar spine.

C. Hassager, B. Riis, M. A. Hansen, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Serum bone Gla-protein as a marker of bone growth in children and adolescents: correlation with age, height, serum insulin-like growth factor I, and serum testosterone.

N. Skakkebaek, N. Skakkebæk, A. Giwercman, 1988, The Journal of clinical endocrinology and metabolism.

Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials.

C. Christiansen, P. Delmas, B. Mitlak, 2000, Archives of internal medicine.

Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links.

C. Christiansen, D. Uebelhart, P. Delmas, 1991, The Journal of clinical endocrinology and metabolism.

Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study.

B. Riis, M. A. Hansen, K. Overgaard, 1991, BMJ.

Prevention and treatment of osteoporosis: a review of current modalities.

C. Christiansen, C. Christiansen, 1992, Bone.

Long-term bone loss in insulin-dependent diabetic patients with microvascular complications.

C. Christiansen, J. Johansen, J. Ditzel, 1990, The Journal of diabetic complications.

CORTICOSTEROID‐INDUCED OSTEOPENIA AND VITAMIN D METABOLISM. EFFECT OF VITAMIN D2, CALCIUM PHOSPHATE AND SODIUM FLUORIDE ADMINISTRATION

C. Christiansen, P. Rødbro, H. Rickers, 1982, Clinical endocrinology.

Effect of 1,25‐dihydroxy ‐ vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis

C. Christiansen, C. Hagen, M. Christensen, 1981, European journal of clinical investigation.

TREATMENT OF POST MENOPAUSAL OSTEOPOROSIS. A CONTROLLED THERAPEUTIC TRIAL COMPARING OESTROGEN/GESTAGEN, 1,25‐DIHYDROXY‐VITAMIN D3 AND CALCIUM

C. Christiansen, I. Transbøl, I. Transbøl, 1982, Clinical endocrinology.

Effect of an energy-restrictive diet, with or without exercise, on lean tissue mass, resting metabolic rate, cardiovascular risk factors, and bone in overweight postmenopausal women.

C. Christiansen, C. Hassager, C Christiansen, 1993, The American journal of medicine.

The effect of the menopause and hormone replacement therapy on serum carboxyterminal propeptide of type I collagen

C. Christiansen, C. Hassager, G. Fabbri-Mabelli, 2005, Osteoporosis International.

Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross‐links: a longitudinal and cross‐sectional study

R. Eastell, C. Hassager, C. Christiansen, 1992 .

The pathophysiology of peri‐ and postmenopausal bone loss

C. Christiansen, L. Nilas, C. Christiansen, 1989, British journal of obstetrics and gynaecology.

Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.

C. Christiansen, J. Reginster, P. Alexandersen, 2001, JAMA.

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.

M. A. Hansen, C. Christiansen, K. Overgaard, 1992, BMJ.

Effect of salcatonin given intranasally on early postmenopausal bone loss.

B. Riis, M. A. Hansen, K. Overgaard, 1989, BMJ.

A 2-Year Phase II Study with 1-Year of Follow-up of Risedronate (NE-58095) in Postmenopausal Osteoporosis

C. Christiansen, J. Reginster, P. Ravn, 1997, Osteoporosis International.

Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study.

C. Christiansen, D. Hosking, M. McClung, 1999, The Journal of clinical endocrinology and metabolism.

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study

M. Drezner, C. Cooper, C. Christiansen, 2005, Annals of the rheumatic diseases.

Dose dependent effects on bone resorption and formation of intermittently administered intravenous ibandronate

C. Christiansen, L. Tankó, L. Wieczorek, 2003, Osteoporosis International.

Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women

C. Christiansen, R. Wasnich, D. Hosking, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Six and Twelve Month Changes in Bone Turnover are Related to Reduction in Vertebral Fracture Risk During 3 Years of Raloxifene Treatment in Postmenopausal Osteoporosis

C. Christiansen, P. Delmas, B. Mitlak, 2001, Osteoporosis International.

Low bone mass and fast rate of bone loss at menopause: equal risk factors for future fracture: a 15-year follow-up study.

B. Riis, M. A. Hansen, K. Overgaard, 1997, Bone.

Design for an ipriflavone multicenter European fracture study

C. Christiansen, J. Reginster, C. Roux, 2009, Calcified Tissue International.

THE DIAGNOSTIC VALIDITY OF LOCAL AND TOTAL BONE MINERAL MEASUREMENTS IN POSTMENOPAUSAL OSTEOPOROSIS AND OSTEOARTHRITIS

C. Christiansen, L. Nilas, B. Riis, 1986, Clinical endocrinology.

Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women.

C. Christiansen, L. Nilas, B. Riis, 1987, American journal of obstetrics and gynecology.

Does oestriol add to the beneficial effect of combined hormonal prophylaxis against early postmenopausal osteoporosis?

C. Christiansen, P. Rødbro, P. Rødbro, 1984, British journal of obstetrics and gynaecology.

Serum concentration of vitamin D metabolites in rheumatoid arthritis

C. Christiansen, B. Riis, O. Als, 1987, Clinical Rheumatology.

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture

Daniel L. Koller, D. Kiel, A. LaCroix, 2012, Nature Genetics.

Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus.

C. Christiansen, S. Madsbad, P. Mcnair, 2009, Acta medica Scandinavica.

The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones.

C. Christiansen, J. Risteli, C. Hassager, 1991, Metabolism: clinical and experimental.

The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure.

C. Christiansen, C. Hassager, B. Riis, 1987, Circulation.

Total and regional body-composition changes in early postmenopausal women: age-related or menopause-related?

C. Christiansen, C. Hassager, P. Ravn, 1994, The American journal of clinical nutrition.

Intermittent Cyclic Tiludronate in the Treatment of Osteoporosis

C. Christiansen, J. Reginster, C. Roux, 2001, Osteoporosis International.

Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits.

C. Christiansen, P. Alexandersen, H. Lawaetz, 1999, Circulation research.

The relationship of natural androgens to coronary heart disease in males: a review.

C. Christiansen, P. Alexandersen, J. Haarbo, 1996, Atherosclerosis.

Blood pressure during oestrogen/progestogen substitution therapy in healthy post-menopausal women.

C. Christiansen, C. Hassager, C. Christiansen, 1988, Maturitas.

Sequential Estrogen and Progestogen Therapy: Assessment of Progestational Effects on the Postmenopausal Endometrium

B. Riis, I. Byrjalsen, L. Thormann, 1992, Obstetrics and Gynecology.

Measurement of spinal or peripheral bone mass to estimate early postmenopausal bone loss?

C. Christiansen, B. Riis, C. Christiansen, 1988, The American journal of medicine.

Progestational effects of combinations of gestodene on the postmenopausal endometrium during hormone replacement therapy.

C. Christiansen, N. Bjarnason, I. Byrjalsen, 1999, American journal of obstetrics and gynecology.

Secretory endometrial protein PP14 in serum from post-menopausal women receiving continuous combined oestradiol-cyproterone acetate: correlation with serum hormone concentrations and bleeding patterns.

C. Christiansen, B. Riis, I. Byrjalsen, 1992, Maturitas.

Automatic morphometric cartilage quantification in the medial tibial plateau from MRI for osteoarthritis grading.

P. Pettersen, E. Dam, J. Folkesson, 2007, Osteoarthritis and cartilage.

Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women.

C. Christiansen, L. Tjellesen, L. Hummer, 1986, Bone and mineral.

Total and local bone mass before and after normalization for indices of bone and body size.

C. Christiansen, L. Nilas, A. Gotfredsen, 1986, Scandinavian journal of clinical and laboratory investigation.

The long-term impact of 2 – 3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women

C. Christiansen, L. Tankó, Y. Bagger, 2006, Climacteric : the journal of the International Menopause Society.

Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group.

C. Christiansen, P. Ravn, B. Clemmesen, 1999, Bone.

Relationship between bone mineral content and frequency of postmenopausal fractures.

C. Christiansen, I. Transbøl, J. Boesen, 2009, Acta medica Scandinavica.

Low Bone Mineral Density in the Hip as a Marker of Advanced Atherosclerosis in Elderly Women

C. Christiansen, L. Tankó, Y. Bagger, 2003, Calcified Tissue International.

NASAL CALCITONIN FOR TREATMENT OF ESTABLISHED OSTEOPOROSIS

C. Christiansen, B. Riis, K. Overgaard, 1989, Clinical endocrinology.

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial

T. Spector, C. Cooper, H. Genant, 2012 .

Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy.

C. Christiansen, J. Jensen, C. Christiansen, 1988, American journal of obstetrics and gynecology.

Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study.

C. Christiansen, P. Alexandersen, B. Riis, 1999, The Journal of clinical endocrinology and metabolism.

Raloxifene inhibits aortic accumulation of cholesterol in ovariectomized, cholesterol-fed rabbits.

C. Christiansen, J. Haarbo, R. Kauffman, 1997, Circulation.

Radiographic measure of aorta calcification is a site‐specific predictor of bone loss and fracture risk at the hip

C. Christiansen, L. Tankó, Y. Bagger, 2006, Journal of internal medicine.

Estrogen/gestagen therapy changes soft tissue body composition in postmenopausal women.

C. Christiansen, C. Hassager, C. Christiansen, 1989, Metabolism: clinical and experimental.

Validation of body composition by dual energy X-ray absorptiometry (DEXA).

C. Christiansen, C. Hassager, A. Gotfredsen, 1991, Clinical physiology.

Tibolone: prevention of bone loss in late postmenopausal women.

C. Christiansen, J. Haarbo, N. Bjarnason, 1996, The Journal of clinical endocrinology and metabolism.

Oral weekly ibandronate prevents bone loss in postmenopausal women

C. Christiansen, D. Felsenberg, L. Tankó, 2003, Journal of internal medicine.

Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial.

C. Christiansen, A. Harris, E. Lau, 2019, Bone.

Accuracy of measurements of body composition by dual-energy x-ray absorptiometry in vivo.

C. Christiansen, C. Hassager, O. Svendsen, 1993, The American journal of clinical nutrition.

Age- and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry.

C. Christiansen, C. Hassager, O. Svendsen, 1995, Metabolism: clinical and experimental.

Spontaneous postmenopausal bone loss in different skeletal areas—followed up for 15 years

C. Christiansen, M. A. Hansen, K. Overgaard, 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Prevalence of Residual Beta-cell Function in Insulin-Dependent Diabetics in Relation to Age at Onset and Duration of Diabetes

C. Christiansen, S. Madsbad, P. Mcnair, 1978, Diabetes.

The influence of thinness and smoking on bone loss and response to hormone replacement therapy in early postmenopausal women.

C. Christiansen, N. Bjarnason, C. Christiansen, 2000, The Journal of clinical endocrinology and metabolism.

Rates of bone loss in normal women: evidence of accelerated trabecular bone loss after the menopause

C. Christiansen, L. Nilas, C. Christiansen, 1988, European journal of clinical investigation.

Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model

C. Christiansen, H. C. Coelingh Bennink, H. Bennink, 2008, Climacteric : the journal of the International Menopause Society.

Dietary calcium intake and blood pressure in normotensive subjects.

C. Christiansen, L. Nilas, K. Thomsen, 2009, Acta medica Scandinavica.

No secular increase in the prevalence of vertebral fractures due to postmenopausal osteoporosis

C. Christiansen, M. A. Hansen, K. Overgaard, 1992, Osteoporosis International.

High bone turnover is associated with low bone mass in both pre- and postmenopausal women.

C. Christiansen, P. Ravn, C. Fledelius, 1996, Bone.

Extended report: Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial

C. Cooper, C. Christiansen, J. Reginster, 2013 .